{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:35:28Z","timestamp":1793306128929,"version":"4.5.0"},"reference-count":194,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.addr.2009.11.020","type":"journal-article","created":{"date-parts":[[2009,11,14]],"date-time":"2009-11-14T09:58:50Z","timestamp":1258192730000},"page":"503-517","source":"Crossref","is-referenced-by-count":178,"title":["Nanotechnology applications for improved delivery of antiretroviral drugs to the brain"],"prefix":"10.1016","volume":"62","author":[{"given":"Ho Lun","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niladri","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Bendayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2009.11.020_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1021070512287","article-title":"HIV-1 replication","volume":"26","author":"Freed","year":"2001","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.addr.2009.11.020_bib2","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1126\/science.280.5371.1884","article-title":"The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens","volume":"280","author":"Wyatt","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.addr.2009.11.020_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0092-8674(00)81430-0","article-title":"HIV entry and its inhibition","volume":"93","author":"Chan","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.addr.2009.11.020_bib4","unstructured":"Joint United Nations Programme on HIV\/AIDS, World Health Organization (WHO), AIDS epidemic update: December 2007. http:\/\/data.unaids.org\/pub\/EPISlides\/2007\/2007_epiupdate_en.pdf. Retrieved on 2009-05-18."},{"key":"10.1016\/j.addr.2009.11.020_bib5","first-page":"767","article-title":"The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus","volume":"312","author":"Dalgliesh","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.addr.2009.11.020_bib6","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1128\/JVI.75.5.2041-2050.2001","article-title":"Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants","volume":"75","author":"Kolchinsky","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2009.11.020_bib7","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/JVI.75.8.3568-3580.2001","article-title":"Differential CD4\/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate","volume":"75","author":"Martin","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2009.11.020_bib8","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1128\/JVI.77.15.8196-8206.2003","article-title":"Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes","volume":"77","author":"Nermut","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2009.11.020_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00002030-199606000-00002","article-title":"Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry","volume":"10","author":"Bagasra","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2009.11.020_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/13550280009091950","article-title":"Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: Potential role of choroid plexus in the pathogenesis of HIV encephalitis","volume":"6","author":"Chen","year":"2000","journal-title":"J. NeuroVirol."},{"key":"10.1016\/j.addr.2009.11.020_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS","volume":"5","author":"Gonz\u00e1lez-Scarano","year":"2005","journal-title":"Nature Rev. Immunol."},{"key":"10.1016\/j.addr.2009.11.020_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0166-2236(99)01453-8","article-title":"Chemokines in the CNS: plurifunctional mediators in diverse states","volume":"22","author":"Asensio","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.addr.2009.11.020_bib13","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1073\/pnas.96.14.8212","article-title":"Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis","volume":"96","author":"Kaul","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.addr.2009.11.020_bib14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1124\/mol.106.025973","article-title":"HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein","volume":"70","author":"Ronaldson","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.020_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/13550289709015806","article-title":"Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures","volume":"3","author":"New","year":"1997","journal-title":"J. Neurovirol"},{"key":"10.1016\/j.addr.2009.11.020_bib16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1126\/science.1063957","article-title":"Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr","volume":"294","author":"De Noronha","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.addr.2009.11.020_bib17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/sj.cdd.4401623","article-title":"HIV-1 infection and AIDS: consequences for the central nervous system","volume":"12","author":"Kaul","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.addr.2009.11.020_bib18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.2326646","article-title":"HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists","volume":"248","author":"Dreyer","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.addr.2009.11.020_bib19","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.274.5294.1917","article-title":"Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41","volume":"274","author":"Adamson","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.addr.2009.11.020_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/13550280390201704","article-title":"Human immunodeficiency virus type 1 tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site","volume":"9","author":"Song","year":"2003","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.addr.2009.11.020_bib21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/jnen\/61.11.992","article-title":"HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia","volume":"61","author":"Kanmogne","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.addr.2009.11.020_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2007.01.004","article-title":"HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia","volume":"185","author":"Ricardo-Dukelow","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.addr.2009.11.020_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1750-3639.2003.tb00014.x","article-title":"Detection of HIV-1 DNA in microglia\/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection","volume":"13","author":"Trillo-Pazos","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.addr.2009.11.020_bib24","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1128\/JVI.78.8.4120-4133.2004","article-title":"CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor","volume":"78","author":"Liu","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2009.11.020_bib25","series-title":"The Practice of Neurosurgery","article-title":"HIV-related central nervous system disorders","author":"Levy","year":"1997"},{"key":"10.1016\/j.addr.2009.11.020_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","article-title":"HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990\u20131998","volume":"56","author":"Sacktor","year":"2001","journal-title":"Neurol."},{"key":"10.1016\/j.addr.2009.11.020_bib27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archneur.1997.00550160054016","article-title":"Neurocognitive impairment is an independent risk factor for death in HIV infection","volume":"54","author":"Ellis","year":"1997","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.addr.2009.11.020_bib28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/mds.870120418","article-title":"AIDS dementia complex with generalized myoclonus","volume":"12","author":"Maher","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.addr.2009.11.020_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1176\/jnp.9.2.277","article-title":"AIDS mania","volume":"9","author":"Lyketsos","year":"1997","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.addr.2009.11.020_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/scientificamerican1088-110","article-title":"AIDS therapies","volume":"259","author":"Yarchoan","year":"1988","journal-title":"Sci. Am."},{"key":"10.1016\/j.addr.2009.11.020_bib31","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents, Department of Health and Health and Human Services, Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents November 3, 2008; 1-139. Available at http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf. Accessed 05-22-09."},{"key":"10.1016\/j.addr.2009.11.020_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jama.300.5.555","article-title":"International AIDS Society-USA, Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel","volume":"300","author":"Hammer","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2009.11.020_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/13550289909021992","article-title":"AIDS program panel meeting on CNS as an HIV-1 reservoir: BBB and drug delivery, September, 1998","volume":"5","author":"Kerza-Kwiatecki","year":"1999","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.addr.2009.11.020_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-4690-3-28","article-title":"HIV-1 associated dementia: symptoms and causes","volume":"3","author":"Ghafouri","year":"2006","journal-title":"Retrovirology"},{"key":"10.1016\/j.addr.2009.11.020_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/13550280390194109","article-title":"Human immunodeficiency virus-associated dementia: an evolving disease","volume":"9","author":"McArthur","year":"2003","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.addr.2009.11.020_bib36","first-page":"94","article-title":"HIV-associated neurocognitive disease continues in the antiretroviral era","volume":"16","author":"Clifford","year":"2008","journal-title":"Top HIV Med."},{"key":"10.1016\/j.addr.2009.11.020_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QAI.0b013e318042e1ee","article-title":"Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors","volume":"45","author":"Tozz","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.addr.2009.11.020_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2006-956759","article-title":"Dementia and neurocognitive disorders due to HIV-1 infection","volume":"27","author":"Ances","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.addr.2009.11.020_bib39","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/JVI.71.3.2059-2071.1997","article-title":"In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues","volume":"71","author":"Wong","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2009.11.020_bib40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.med.53.082901.104024","article-title":"The challenge of viral reservoirs in HIV-1 infection","volume":"53","author":"Blankson","year":"2002","journal-title":"Ann. Rev. Med."},{"key":"10.1016\/j.addr.2009.11.020_bib41","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/518250","article-title":"Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implication for eradication of virus","volume":"195","author":"Chun","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.020_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1310\/AW2H-TP5C-NP43-K6BY","article-title":"HIV pharmacology: barriers to the eradication of HIV from the CNS","volume":"7","author":"McGee","year":"2006","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.addr.2009.11.020_bib43","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1517\/14656566.7.12.1541","article-title":"Current status of antiretroviral therapy","volume":"7","author":"Temesgen","year":"2006","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.addr.2009.11.020_bib44","first-page":"1275","volume":"66","author":"Oldfield","year":"2006","journal-title":"Lopinavir\/ritonavir: a review of its use in the management of HIV infection"},{"key":"10.1016\/j.addr.2009.11.020_bib45","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.2165\/00003495-200565150-00015","article-title":"Nelfinavir: a review of its use in the management of HIV infection","volume":"65","author":"Perry","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2009.11.020_bib46","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2165\/00003495-200565160-00010","article-title":"Atazanavir: a review of its use in the management of HIV infection","volume":"65","author":"Swainston","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2009.11.020_bib47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/00023210-200216090-00002","article-title":"Clinical implications of CNS penetration of antiretroviral drugs","volume":"16","author":"Wynn","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.addr.2009.11.020_bib48","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2174\/1381612043384835","article-title":"Anti-HIV drug distribution to the central nervous system","volume":"10","author":"Thomas","year":"2004","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/j.addr.2009.11.020_bib49","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.addr.2004.07.008","article-title":"Peptide and peptide analog transport systems at the blood-CSF barrier","volume":"56","author":"Smith","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.020_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.11.089","article-title":"Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy","volume":"1134","author":"Yousif","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2009.11.020_bib51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1469-7580.2007.00812.x","article-title":"Establishment of a human in vitro model of the outer blood-retinal barrier","volume":"211","author":"Hamilton","year":"2007","journal-title":"J. Anat."},{"key":"10.1016\/j.addr.2009.11.020_bib52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1359-6446(00)01632-9","article-title":"Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (part 1)","volume":"6","author":"Kusuhara","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2009.11.020_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6107(02)00037-8","article-title":"Tight junction proteins","volume":"81","author":"Gonz\u00e1lez-Mariscal","year":"2003","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.addr.2009.11.020_bib54","series-title":"The physiology and pathophysiology of the cerebrospinal fluid","first-page":"375","author":"Davson","year":"1987"},{"key":"10.1016\/j.addr.2009.11.020_bib55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00126334-200406010-00001","article-title":"Transport of HIV protease inhibitors through the blood-brain: interactions of P-glycoprotein and HIV protease inhibitors","volume":"36","author":"Gimenez","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.addr.2009.11.020_bib56","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.GR-1649R","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res."},{"key":"10.1016\/j.addr.2009.11.020_bib57","unstructured":"M. Dean, National Library of Medicine (US), NCBI, The human ATP-binding cassette (ABC) transporter superfamily. http:\/\/www.ncbi.nlm.nih.gov\/bookshelf\/br.fcgi?book=mono_001&part=A137. 2002, Accessed 05-24-09."},{"key":"10.1016\/j.addr.2009.11.020_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature05626","article-title":"Structure of an ABC transporter in complex with its binding protein","volume":"446","author":"Hollenstein","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.addr.2009.11.020_bib59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.addr.2009.11.020_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0928-0987(00)00114-7","article-title":"Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs","volume":"11","author":"Krishna","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2009.11.020_bib61","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1139\/o06-199","article-title":"Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1)","volume":"84","author":"Sharom","year":"2006","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.addr.2009.11.020_bib62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/pr.58.2.3","article-title":"Multidrug resistance-associated proteins: expression and function in the central nervous system","volume":"58","author":"Dallas","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.addr.2009.11.020_bib63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1083\/jcb.131.1.137","article-title":"Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport- deficient mutant hepatocytes","volume":"131","author":"Mayer","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2009.11.020_bib64","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI119886","article-title":"Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA","volume":"101","author":"Evers","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2009.11.020_bib65","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc Natl. Acad. Sci. USA"},{"key":"10.1016\/j.addr.2009.11.020_bib66","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2009.11.020_bib67","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/jac\/dkm353","article-title":"Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes","volume":"60","author":"Janneh","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2009.11.020_bib68","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00002030-200107270-00004","article-title":"P-glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance","volume":"15","author":"Jones","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2009.11.020_bib69","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1023\/B:PHAM.0000026433.27773.47","article-title":"Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines","volume":"21","author":"Ronaldson","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.020_bib70","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1021\/bi972709x","article-title":"HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter","volume":"37","author":"Lee","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2009.11.020_bib71","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0090-9556(24)15186-0","article-title":"The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells","volume":"28","author":"Washington","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2009.11.020_bib72","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/01.aids.0000194793.36175.40","article-title":"Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP","volume":"19","author":"Janneh","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2009.11.020_bib73","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00001756-200405190-00020","article-title":"Multidrug resistance protein 1-mediated transport of saquinavir by microglia","volume":"15","author":"Dallas","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.addr.2009.11.020_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.103.054304","article-title":"Functional expression of the multidrug resistance protein 1 in microglia","volume":"307","author":"Dallas","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2009.11.020_bib75","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jemt.10090","article-title":"Functional expression and localization of P-glycoprotein at the blood brain barrier","volume":"57","author":"Bendayan","year":"2002","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.addr.2009.11.020_bib76","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0022-3565(24)29319-8","article-title":"Functional expression of P-glycoprotein in rat brain microglia","volume":"299","author":"Lee","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2009.11.020_bib77","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1124\/dmd.104.002931","article-title":"Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro","volume":"33","author":"Perloff","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2009.11.020_bib78","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1023\/A:1025092829696","article-title":"Rapid assessment of P-glycoprotein inhibition and induction in vitro","volume":"20","author":"Perloff","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.020_bib79","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1177\/009127002762491370","article-title":"Fexofenadine transport in Caco-2 cells: Inhibition with verapamil and ritonavir","volume":"42","author":"Perloff","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.020_bib80","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1126\/science.7824938","article-title":"Transcription factor ATF2 regulation by the JNK signal transduction pathway","volume":"267","author":"Gupta","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.addr.2009.11.020_bib81","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/dmd.106.012765","article-title":"Inhibition of MRP1\/ABCC1, MRP2\/ABCC2, and MRP3\/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors","volume":"35","author":"Weiss","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2009.11.020_bib82","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bcp.2007.01.027","article-title":"Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein","volume":"73","author":"Storch","year":"2007","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.addr.2009.11.020_bib83","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/12487","article-title":"MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs","volume":"5","author":"Schuetz","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2009.11.020_bib84","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1124\/mol.63.5.1094","article-title":"Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5","volume":"63","author":"Reid","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.020_bib85","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/glia.20725","article-title":"Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection","volume":"56","author":"Ronaldson","year":"2008","journal-title":"GLIA"},{"key":"10.1016\/j.addr.2009.11.020_bib86","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/mol.58.6.1357","article-title":"Xenobiotic transport across isolated brain microvessels studied by confocal microscopy","volume":"58","author":"Miller","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.020_bib87","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1471-4159.2004.02417.x","article-title":"Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures","volume":"89","author":"Ronaldson","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2009.11.020_bib88","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1124\/dmd.108.020974","article-title":"Investigation of the role of breast cancer resistance protein (Bcrp\/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse","volume":"36","author":"Giri","year":"2008","journal-title":"Drug Metab. Disp."},{"key":"10.1016\/j.addr.2009.11.020_bib89","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0090-9556(24)15144-6","article-title":"Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes","volume":"28","author":"Choo","year":"2000","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.addr.2009.11.020_bib90","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/jpet.104.076216","article-title":"P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice","volume":"312","author":"Park","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2009.11.020_bib91","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/jps.20344","article-title":"The impact of pharmacologic and genetic knockout of P-glycoprotein on nelfinavir levels in the brain and other tissues in mice","volume":"94","author":"Salama","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2009.11.020_bib92","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2990.1988.tb01338.x","article-title":"Structural changes in the rat brain after carotid infusions of hyperosmolar solutions: a light microscopic and immunohistochemical study","volume":"14","author":"Salahuddin","year":"1988","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.addr.2009.11.020_bib93","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1227\/00006123-198409000-00011","article-title":"Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening","volume":"15","author":"Neuwelt","year":"1984","journal-title":"Neurosurgery"},{"key":"10.1016\/j.addr.2009.11.020_bib94","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cncr.22450","article-title":"Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis","volume":"109","author":"Fortin","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.addr.2009.11.020_bib95","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1023\/A:1011016923346","article-title":"P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier","volume":"18","author":"van der Sandt","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.020_bib96","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neulet.2008.10.080","article-title":"Bradykinin-induced blood-tumor barrier opening is mediated by tumor necrosis factor-alpha","volume":"450","author":"Qin","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.addr.2009.11.020_bib97","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.jcbfm.9600534","article-title":"Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain","volume":"28","author":"Sood","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.addr.2009.11.020_bib98","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","article-title":"Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells J","volume":"29","author":"Fleegal-DeMotta","year":"2009","journal-title":"Cereb. Blood Flow Metab."},{"key":"10.1016\/j.addr.2009.11.020_bib99","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00002018-200629030-00005","article-title":"Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II \u2014 mechanisms of action, pharmacokinetics and toxicity profile","volume":"29","author":"Hartmann","year":"2006","journal-title":"Drug Safety"},{"key":"10.1016\/j.addr.2009.11.020_bib100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6793-5-2","article-title":"Effect of bradykinin on nitric oxide production, urea synthesis and viability of rat hepatocyte cultures","volume":"5","author":"Sesti","year":"2005","journal-title":"BMC Physiology"},{"key":"10.1016\/j.addr.2009.11.020_bib101","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4161\/cc.7.7.5625","article-title":"Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition","volume":"7","author":"Poruchynsky","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.addr.2009.11.020_bib102","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1023\/A:1016299507382","article-title":"Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats","volume":"12","author":"Anderson","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.020_bib103","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.ultrasmedbio.2005.07.010","article-title":"MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits","volume":"31","author":"McDannold","year":"2005","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.addr.2009.11.020_bib104","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.pbiomolbio.2006.07.019","article-title":"Ultrasound, microbubbles and the blood-brain barrier","volume":"93","author":"Meairs","year":"2007","journal-title":"Prog. Biophy. Mol. Biol."},{"key":"10.1016\/j.addr.2009.11.020_bib105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ultras.2008.04.004","article-title":"Progress and problems in the application of focused ultrasound for blood-brain barrier disruption","volume":"48","author":"Vykhodtseva","year":"2008","journal-title":"Ultrasonics"},{"key":"10.1016\/j.addr.2009.11.020_bib106","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ejpb.2008.06.020","article-title":"Exploring the use of novel drug delivery systems for antiretroviral drugs","volume":"70","author":"Ojewole","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2009.11.020_bib107","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/10717540802321776","article-title":"Polymeric nanoparticles for enhancing antiretroviral drug therapy","volume":"15","author":"Govender","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2009.11.020_bib108","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.jcbfm.9600414","article-title":"Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis","volume":"27","author":"Spitzenberger","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.addr.2009.11.020_bib109","first-page":"157","article-title":"Role of nanotechnology in HIV\/AIDS treatment: potential to overcome the viral reservoir challenge","volume":"6","author":"Amiji","year":"2006","journal-title":"Discovery Med."},{"key":"10.1016\/j.addr.2009.11.020_bib110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.5.4.371","article-title":"Advances in PEGylation of important biotech molecules: delivery aspects","volume":"5","author":"Ryan","year":"2008","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2009.11.020_bib111","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/pr.58.1.8","article-title":"Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery","volume":"58","author":"Khalil","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.addr.2009.11.020_bib112","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1078\/1438-4221-00157","article-title":"Origin, originality, functions, subversions and molecular signaling of macropinocytosis","volume":"291","author":"Amyere","year":"2002","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.addr.2009.11.020_bib113","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2004.10.018","article-title":"Cationic TAT peptide transduction domain enters cells by macropinocytosis","volume":"102","author":"Kaplan","year":"2005","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2009.11.020_bib114","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/35074539","article-title":"Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER","volume":"3","author":"Pelkmans","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.addr.2009.11.020_bib115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2005.09.040","article-title":"Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases","volume":"314","author":"Popovic","year":"2006","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.addr.2009.11.020_bib116","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2004.07.006","article-title":"Paclitaxel nanoparticles for the potential treatment of brain tumors","volume":"99","author":"Koziara","year":"2004","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2009.11.020_bib117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10611860108997929","article-title":"Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro","volume":"9","author":"Alyaudtin","year":"2001","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2009.11.020_bib118","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2005.11.040","article-title":"Influence of particle size on transport of methotrexate across blood-brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles","volume":"310","author":"Gao","year":"2006","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.addr.2009.11.020_bib119","first-page":"44","article-title":"Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles","volume":"41","author":"Alyautdin","year":"1995","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2009.11.020_bib120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1602\/neurorx.2.1.108","article-title":"Drug transport to brain with targeted nanoparticles","volume":"2","author":"Olivier","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.addr.2009.11.020_bib121","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2006.07.044","article-title":"Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier","volume":"327","author":"Kuo","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.020_bib122","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1021\/cr040002s","article-title":"Controlled ring-opening polymerization of lactide and glycolide","volume":"104","author":"Dechy-Cabaret","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2009.11.020_bib123","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jbm.a.31998","article-title":"The modification of PLA and PLGA using electron-beam radiation","volume":"89","author":"Leonard","year":"2009","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2009.11.020_bib124","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/erm.09.15","article-title":"Current advances in research and clinical applications of PLGA-based nanotechnology","volume":"9","author":"Lu","year":"2009","journal-title":"Exp. Rev. Mol. Diagn."},{"key":"10.1016\/j.addr.2009.11.020_bib125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2007.05.026","article-title":"Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration","volume":"121","author":"Gao","year":"2007","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2009.11.020_bib126","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.biomaterials.2005.12.021","article-title":"Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery","volume":"27","author":"Kim","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2009.11.020_bib127","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2008.09.023","article-title":"Dendrimers as versatile platform in drug delivery applications","volume":"71","author":"Svenson","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2009.11.020_bib128","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1096\/fj.06-7380com","article-title":"Efficient gene delivery targeted to the brain using a transferring-conjugated polyethylene glycol-modified polyamidoamine dendrimer","volume":"21","author":"Huang","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2009.11.020_bib129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/mp700086j","article-title":"Methotrexate loaded polyether\u2013copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability","volume":"5","author":"Dhanikula","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2009.11.020_bib130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bbagen.2006.12.007","article-title":"Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly(propyleneimine) dendrimer","volume":"1770","author":"Dutta","year":"2007","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.addr.2009.11.020_bib131","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v25.i6.20","article-title":"A review of the application of lipid-based systems in systemic, dermal\/transdermal, and ocular drug delivery","volume":"25","author":"Gershkovich","year":"2008","journal-title":"Crit. Rev. Ther. Drug Carrier Sys."},{"key":"10.1016\/j.addr.2009.11.020_bib132","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/187221107782331593","article-title":"Liposomal drug delivery: recent patents and emerging opportunities","volume":"1","author":"Webb","year":"2007","journal-title":"Recent Patents Drug Delivery Formulation"},{"key":"10.1016\/j.addr.2009.11.020_bib133","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/187221108784534081","article-title":"Recent advances and patents on solid lipid nanoparticles","volume":"2","author":"Sawant","year":"2008","journal-title":"Recent Patents Drug Delivery Formulation"},{"key":"10.1016\/j.addr.2009.11.020_bib134","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.2042-7158.1994.tb03252.x","article-title":"Liposomes as in vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusion","volume":"46","author":"Fresta","year":"1994","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.020_bib135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2745\/dds.10.425","article-title":"Basic experiment of BBB permeability of cisplatin encapsulated in liposome by means of in vitro BBB","volume":"10","author":"Anda","year":"1995","journal-title":"Drug Deliv. Syst."},{"key":"10.1016\/j.addr.2009.11.020_bib136","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(95)01095-5","article-title":"Liposome-entrapped phenytoin locally suppresses amygdaloid epileptogenic focus created by db-cAMP\/EDTA in rats","volume":"703","author":"Mori","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2009.11.020_bib137","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1211\/jpp.58.5.0005","article-title":"Stavudine-loaded mannosylated liposomes: in vitro anti-HIV-I activity, tissue distribution and pharmacokinetics","volume":"58","author":"Garg","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.020_bib138","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/10611860802475688","article-title":"Lymphatic targeting of zidovudine using surface-engineered liposomes","volume":"16","author":"Kaur","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2009.11.020_bib139","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00002030-199508000-00002","article-title":"Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics","volume":"9","author":"Dusserre","year":"1995","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2009.11.020_bib140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/1061186031000115150","article-title":"The study on brain targeting of the amphotericin B liposomes","volume":"11","author":"Zhang","year":"2003","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2009.11.020_bib141","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.016","article-title":"Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations","volume":"347","author":"Vyas","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.020_bib142","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.addr.2007.04.008","article-title":"Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles","volume":"59","author":"Wong","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.020_bib143","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1023\/A:1012043315093","article-title":"Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surface","volume":"14","author":"Muller","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.020_bib144","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1007\/s11095-008-9615-2","article-title":"Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line","volume":"25","author":"Chattopadhyay","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.020_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i1.10","article-title":"Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers","volume":"19","author":"Kabanov","year":"2002","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.addr.2009.11.020_bib146","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11481-008-9119-1","article-title":"Effect of Pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells","volume":"4","author":"Zhang","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.addr.2009.11.020_bib147","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1124\/jpet.102.043307","article-title":"Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells","volume":"304","author":"Batrakova","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2009.11.020_bib148","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1023\/A:1018990706838","article-title":"Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers","volume":"16","author":"Batrakova","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.020_bib149","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-3659(03)00211-6","article-title":"An essential relationship between ATP depletion and chemosensitizing activity of Pluronic\u00ae block copolymers","volume":"91","author":"Kabanov","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2009.11.020_bib150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2004.12.007","article-title":"Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating","volume":"1035","author":"MacKay","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2009.11.020_bib151","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood-brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2009.11.020_bib152","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-3565(24)35204-8","article-title":"Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier","volume":"291","author":"Fenart","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2009.11.020_bib153","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1023\/A:1016274801930","article-title":"Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs","volume":"12","author":"Liu","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.020_bib154","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1002\/jps.21190","article-title":"Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways","volume":"97","author":"Kerwin","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2009.11.020_bib155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10611860500071292","article-title":"Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns","volume":"13","author":"Goppert","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2009.11.020_bib156","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1022604120952","article-title":"Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles","volume":"20","author":"Kreuter","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.020_bib157","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.105.097139","article-title":"Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain","volume":"317","author":"Michaelis","year":"2006","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.addr.2009.11.020_bib158","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0022-3565(24)36946-0","article-title":"Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat","volume":"282","author":"Huwyler","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2009.11.020_bib159","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.addr.2009.11.020_bib160","first-page":"333","article-title":"Analysis of lymphopoietic stem cells with a monoclonal antibody to the rat transferrin receptor","volume":"54","author":"Jefferies","year":"1985","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2009.11.020_bib161","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1019842024814","article-title":"Synthesis of pegylated immunonanoparticles","volume":"19","author":"Olivier","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.020_bib162","first-page":"1766","article-title":"Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology","volume":"45","author":"Suzuki","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2009.11.020_bib163","first-page":"937","article-title":"Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody","volume":"26","author":"Wu","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2009.11.020_bib164","first-page":"93","article-title":"Peptide drug delivery across the blood-brain barrier","volume":"39","author":"Pardridge","year":"1996","journal-title":"Proc. West Pharmacol. Soc."},{"key":"10.1016\/j.addr.2009.11.020_bib165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bit.21120","article-title":"Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier","volume":"96","author":"Boado","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.addr.2009.11.020_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717540590889556","article-title":"PEGylated immunoliposomes directed against brain astrocytes","volume":"12","author":"Chekhonin","year":"2005","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2009.11.020_bib167","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/10611860500206674","article-title":"Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects","volume":"13","author":"Schnyder","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2009.11.020_bib168","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ics.2005.02.024","article-title":"Single domain antibodies as blood-brain barrier delivery vector","volume":"1277","author":"Abulrob","year":"2005","journal-title":"Int. Congr. Ser. - Drug Transport(ers) Diseased Brain"},{"key":"10.1016\/j.addr.2009.11.020_bib169","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1471-4159.2005.03463.x","article-title":"The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells","volume":"95","author":"Abulrob","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2009.11.020_bib170","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M010908200","article-title":"Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase","volume":"276","author":"Kim","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2009.11.020_bib171","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1631\/jzus.2005.B0668","article-title":"Extracellular HIV Tat and Tat cysteine rich peptide increase CCR5 expression in monocytes","volume":"6","author":"Zheng","year":"2005","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.addr.2009.11.020_bib172","doi-asserted-by":"crossref","first-page":"18188","DOI":"10.1074\/jbc.271.30.18188","article-title":"Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent","volume":"271","author":"Derossi","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2009.11.020_bib173","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.addr.2009.11.020_bib174","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/JVI.65.2.961-967.1991","article-title":"Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1","volume":"65","author":"Sabatier","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2009.11.020_bib175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00042560-199908150-00003","article-title":"Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir","volume":"21","author":"Kravcik","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.addr.2009.11.020_bib176","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biopha.2008.07.086","article-title":"Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell penetrating peptide","volume":"63","author":"Wei","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2009.11.020_bib177","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/oli.2008.0140","article-title":"Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element","volume":"18","author":"Ganguly","year":"2008","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.addr.2009.11.020_bib178","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1747-0285.2008.00769.x","article-title":"Antimicrobial and cytolytic activities and plausible mode of bactericidal action of the cell penetrating peptide penetratin and its lys-linked two-stranded peptide","volume":"73","author":"Zhu","year":"2009","journal-title":"Chem. Biol. Drug Design"},{"key":"10.1016\/j.addr.2009.11.020_bib179","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2005.09.032","article-title":"Present and future of cell-penetrating peptide mediated delivery systems: is the Trojan horse too wild to go only to Troy","volume":"109","author":"Vives","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2009.11.020_bib180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.virol.2006.08.012","article-title":"Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte derived macrophages","volume":"358","author":"Dou","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.addr.2009.11.020_bib181","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jps.20718","article-title":"Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems","volume":"96","author":"Illum","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2009.11.020_bib182","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","article-title":"Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration","volume":"27","author":"Gao","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2009.11.020_bib183","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0166-3542(01)00163-2","article-title":"Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5)","volume":"52","author":"Ruff","year":"2001","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2009.11.020_bib184","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jconrel.2006.09.007","article-title":"Combinational treatment with doxorubicin and GG918 (Elacridar) using polymer-lipid hybrid nanoparticles (PLN) and evaluation of strategies for multidrug-resistance reversal in human breast cancer cells","volume":"116","author":"Wong","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2009.11.020_bib185","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/jps.20100","article-title":"Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers","volume":"93","author":"Wong","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2009.11.020_bib186","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1124\/jpet.105.088328","article-title":"In vivo evaluation of P-glycoprotein function at the blood-brain barrier in non human primates using [11C] verapamil","volume":"316","author":"Lee","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2009.11.020_bib187","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2008.08.021","article-title":"Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB)","volume":"71","author":"Ulbrich","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2009.11.020_bib188","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bit.21120","article-title":"Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier","volume":"96","author":"Boado","year":"2007","journal-title":"Biotechnol. Bioengin."},{"key":"10.1016\/j.addr.2009.11.020_bib189","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-510X(98)00021-5","article-title":"Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain-barrier dysfunction","volume":"156","author":"Giovannoni","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.addr.2009.11.020_bib190","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ana.410320509","article-title":"Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain","volume":"32","author":"Petito","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2009.11.020_bib191","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10571-004-1383-x","article-title":"Mechanisms of the blood-brain barrier disruption in HIV-1 infection","volume":"25","author":"Toborek","year":"2005","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.addr.2009.11.020_bib192","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0169-409X(03)00108-X","article-title":"Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates","volume":"55","author":"Caliceti","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.020_bib193","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00137696-200503030-00004","article-title":"Pharmacoscintigraphic evaluation of polysorbate80-coated chitosan nanoparticles for brain targeting","volume":"3","author":"Soni","year":"2005","journal-title":"Amer. J. Drug Del."},{"key":"10.1016\/j.addr.2009.11.020_bib194","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00137696-200503030-00002","article-title":"Potential of transferrin and transferrin conjugates of liposomes in drug delivery and targeting","volume":"3","author":"Soni","year":"2005","journal-title":"Amer. J. Drug Deliv."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X09003615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X09003615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T06:49:59Z","timestamp":1739429399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X09003615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":194,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0169409X09003615"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2009.11.020","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}